- The Dish’s Weekly Biotechnology News Wrap Up – April 21, 2017Posted 4 days ago
- Glycosylation Overview and How to Control Glycosylation using In Vitro GlycoengineeringPosted 6 days ago
- A Novel Approach for Expansion of High Quality Mesenchymal Stem CellsPosted 7 days ago
- Cell Therapy Clinical Trials: Navigating the operational shift from Phase 1 to Phase 2Posted 1 week ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 14, 2017Posted 2 weeks ago
- GMP Proteins for Cell Therapy Manufacturing: Top 6 Things to KnowPosted 2 weeks ago
- Smart Cell Culture Monitoring – Transforming the way we look at cells in culturePosted 2 weeks ago
- A Primer on Primary Cells and CulturePosted 2 weeks ago
- The Importance of Resin Selection in Development of a Platform Bioprocess FilmPosted 2 weeks ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 7, 2017Posted 3 weeks ago
More Regulatory News
The Number of FDA Drug Approvals for the 2012 Fiscal Year Remains High
In a recent report issued by the Food and Drug Administration (FDA) “Fiscal Year...
- Posted December 13, 2012
FDA Strives to Provide Faster Approval Time for Drugs by Employing “Special Medical Use” Category
Last month the President’s Council of Advisors on Science and Technology (PCAST) released “Report...
- Posted October 17, 2012
Key Considerations for Improved Quality in Biopharmaceutical Manufacturing
In July, the Food and Drug Administration (FDA) issued a warning letter to Sanofi...
- Posted September 20, 2012
Part II – Ten Companies with Innovative Stem Cell Therapies in Clinical Trials
As discussed in our previous blog “Ten Companies with Innovative Stem Cell Therapies in...
- Posted September 12, 2012
Ten Companies with Innovative Stem Cell Therapies in Clinical Trials – Part I
Two stem cell therapies have received approval in other countries, but none so far...
- Posted September 5, 2012